In this article, we will look at the best get rich quick stocks to buy right now.

At a time when many investors are seeking life-changing opportunities, stocks capable of generating outsized returns continue to attract significant interest. While there is no such thing as a guaranteed “get rich quick” investment, history has shown that some companies have benefited from transformational trends and successful turnarounds. This, in turn, helped generate outsized returns in a relatively short time.

However, stronger returns are difficult to attain in the current volatile markets. On June 30, Reuters published an article titled “AI spending, earnings hopes, Fed outlook set to sway US stocks in second half,” outlining that the U.S. stock market faces several challenges in sustaining its rally in the second half of this year. These hurdles include the sustainability of AI spending, elevated corporate earnings expectations, and the Federal Reserve’s interest-rate outlook under new leadership.

So far, the S&P 500 has jumped over 8% this year, continuing a bull run that has lasted more than three years. In contrast, the Nasdaq Composite has risen 11%. However, investors have turned more cautious now given the June pullback.

With this backdrop in mind, we have compiled a list of the best get rich quick stocks to buy right now.

Our Methodology

For this article, we considered stocks with a market capitalization between 300 million and 3 billion. Next, we filtered for stocks with a 5-year beta between 1.5 and 3, upside potential of over 50%, and average daily volume over the last 20 trading days of at least 1 million. We then shortlisted the companies with the highest upside potential and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are ranked by upside potential in ascending order.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).

10. Dauch Corporation (NYSE:DCH)

Upside Potential as of July 2, 2026: 60.82%

On June 22, Barclays reinstated coverage of Dauch Corporation (NYSE:DCH) with an Equal Weight rating and a price target of $8. This follows the Dowlais Group acquisition, which the firm believes expands the company’s offerings but raises concerns about its exposure to China and the European Union.

Additionally, Barclays highlighted that Dauch Corporation (NYSE:DCH) has a “key” North America internal combustion engine business. The company also has exposure to General Motors and Ram, the analyst added. With a focus on strengthening the balance sheet, the company remains committed to reducing the outstanding debt.

Looking ahead, Dauch Corporation (NYSE:DCH) targets sales between $10.3 billion and $10.5 billion, compared with the previous estimated range of $10.3 billion to $10.7 billion. This narrowed target is driven by current global production assumptions. For EBITDA, management projects a range of $1.3 billion-$1.425 billion versus an earlier guidance of $1.3 billion-$1.4 billion. That said, with an upside potential of 60.82%, DCH is one of the best get rich quick stocks to buy.

Dauch Corporation (NYSE:DCH) is a Michigan-based company specializing in driveline and metal forming technologies for a range of vehicles. Founded in 1994, the company operates through two segments: Driveline and Metal Forming.

9. PureCycle Technologies, Inc. (NASDAQ:PCT)

Upside Potential as of July 2, 2026: 70.83%

On June 16, Alembic Global cut the price target on PureCycle Technologies, Inc. (NASDAQ:PCT) to $16, down from $18. This implies an upside potential of approximately 110%. The firm maintains an Overweight rating on the shares.

Previously, on June 12, Northland also trimmed the price target on PureCycle Technologies, Inc. (NASDAQ:PCT) to $13 from $14 and reiterated an Outperform rating. This followed updates to guidance to better reflect the $395 million capital raise. As highlighted by the analyst, the company has been making “nice progress” with four consecutive quarters of sequential revenue growth. Having said that, the firm views a potential accelerated growth inflection in the latter half of 2026.

In Q1 FY2026, PureCycle Technologies, Inc. (NASDAQ:PCT) kept its project spend projections between $39 million and $45 million unchanged. What solidifies the company’s positioning is its financing optionality. The company has a $200 million revolving credit facility, which is available through September next year, in addition to roughly $75 million in revenue bonds.

PureCycle Technologies, Inc. (NASDAQ:PCT) is a Florida-based company that produces recycled polypropylene. Founded in 2015, the company recycles waste polypropylene into virgin polymer.

8. Bed Bath & Beyond, Inc. (NYSE:BBBY)

Upside Potential as of July 2, 2026: 71.53%

On June 23, Wedbush assumed coverage on Bed Bath & Beyond, Inc. (NYSE:BBBY) with an Outperform rating and a $10 price target, up from $8. The firm believes the company is a misunderstood turnaround story under Marcus Lemonis, noting that the market is mispricing it as a declining e-commerce business and overlooking its broader “Everything Home” platform strategy.

In addition to strengthening margins, cross-segment synergies, and operating leverage that spans multiple years, the company’s strategy is projected to generate nearly $3 billion in annual revenue. Indeed, Bed Bath & Beyond, Inc. (NYSE:BBBY) is one of the best get rich quick stocks to buy right now.

Back on June 18, Bed Bath & Beyond, Inc. (NYSE:BBBY) announced the first phase of its nationwide launch of a new format combining Bed Bath & Beyond and The Container Store. This will bring home essentials, storage and organization, custom spaces, and home services under one platform.

As said by the company,

“The first 22 locations will begin welcoming customers to the new format immediately, with additional stores scheduled to convert over the coming several weeks as the company continues its nationwide transformation.”

Bed Bath & Beyond, Inc. (NYSE:BBBY), founded in 1997, provides an e-commerce platform that offers furniture and home furnishing products and services.

7. Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY)

Upside Potential as of July 2, 2026: 81.16%

On June 29, Citizens started coverage on Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) with a Market Perform rating and without a price target. Despite its discounted valuation, the company appears fairly valued due to the limited visibility on same-store sales growth. This comes after many years of weak performance. The company has a negative three-year return of 75.22%, in contrast to the S&P 500’s positive return of 68.15%.

Citizens is waiting for a more attractive entry point, with the company’s traffic trends starting to improve. Offering 81.16% upside potential, Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) emerges as one of the best get rich quick stocks to buy right now.

Back on June 16, Andrew Strelzik from BMO Capital trimmed the price target on Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) to $22 from $24 and reaffirmed an Outperform rating. Muted comps and sales deleverage resulted in Q1 EBITDA below consensus estimates, at $14 million. The firm’s rating is driven by the stock’s appealing risk/reward profile, favorable business changes, and readiness to redirect capex from store growth to reinvestment.

Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) is a Texas-based company that owns and manages entertainment and dining venues. The company also provides food, drinks, and entertainment.

6. Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Upside Potential as of July 2, 2026: 86.03%

On June 23, Kieran Ryan from Deutsche Bank started coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a Hold rating and a price target of $15.50. The firm highlighted the current transition to PayGo pharmacy, which it believes is a “transformational shift” to the company’s economic model. The stock appears fairly valued given the company’s “substantial” execution risk and complexity amid many shifts, the firm concluded.

Back on June 5, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) announced that it had received the CE mark for expanded indications for its automated insulin delivery systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems, leveraging Control-IQ+ AID technology, are approved for people living with type 1 diabetes during pregnancy and for adults with type 2 diabetes.

“These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” commented John Sheridan, president and chief executive officer. “By expanding access to our AID technology, we’re broadening our impact and advancing our mission to improve lives across the diabetes community.”

Overall, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has a Buy rating from more than half of the analysts covering the stock, with the remaining having a neutral stance. The company’s upside potential of 86.03% makes it one of the best get rich quick stocks to buy right now.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a California-based company specializing in technology solutions for diabetes patients. Incorporated in 2006, the company also provides single-use products.

5. Hertz Global Holdings, Inc. (NASDAQ:HTZ)

Upside Potential as of July 2, 2026: 135.85%

On June 30, Andrew Percoco from Morgan Stanley trimmed the price target on Hertz Global Holdings, Inc. (NASDAQ:HTZ) to $3.50 from $5 and reaffirmed an Equal Weight rating. The firm has lowered its 2026 adjusted EBITDA estimate by 40%, bringing it to $213 million. This reflects a 2.4% margin, down from the previous projection of $359 million at a 4% margin, due to higher per-unit depreciation.

Morgan Stanley has increased its depreciation per unit estimate for Q2 FY2026 to $300, up from $253, based on the revised guidance from management. With that said, the firm expects increased depreciation per unit to persist through the third and fourth quarters. For the full year 2026, the firm has now raised its projection to $298 from $281.

On June 25, JPMorgan analyst Rajat Gupta stated that the company’s Q2 pre-announcement reflects a stronger-than-expected uptick in net depreciation per unit, associated with softening in the used-car industry. While Hertz Global Holdings, Inc. (NASDAQ:HTZ) delivered the strongest YoY revenue growth in three years in Q1, the stock has delivered negative returns in the past year. But with an upside potential of 135.85%, HTZ remains one of the best get rich quick stocks to buy.

Hertz Global Holdings, Inc. (NASDAQ:HTZ) is a Florida-based vehicle rental company. Founded in 1918, the company operates through the Americas RAC and International RAC segments.

4. FTAI Infrastructure Inc. (NASDAQ:FIP)

Upside Potential as of July 2, 2026: 136.49%

On July 1, Jones Trading started coverage on FTAI Infrastructure Inc. (NASDAQ:FIP) with a Buy rating and a price target of $8.75. As the lowest 1-year price estimate, the firm’s target reflects an upside potential of 97.07% from the current level.

As noted by the analyst, the company is working towards monetizing the Jefferson and Repauno assets. The proceeds from these will likely be redirected toward the rail segment. While highlighting the company’s shift to a short-line freight rail concentration, the firm said that FTAI Infrastructure Inc. (NASDAQ:FIP) shares are trading at “a significant discount to peers.”

During the company’s FY2026 earnings call, management highlighted the agreement to sell Long Ridge to MARA Holdings. Valued at $1.52 billion, the transaction is expected to close in the third quarter. What puts FTAI Infrastructure Inc. (NASDAQ:FIP) in a strong position is its higher cash flow and additional debt capacity, which will help to make investments in the rail sector. With an upside potential of 136.49%, FIP is one of the best get rich quick stocks to invest in.

FTAI Infrastructure Inc. (NASDAQ:FIP) is a New York-based company that acquires and manages assets representing infrastructure. Founded in 2021, the company operates through Railroad, Ports and Terminals, Power and Gas, and Sustainability and Energy Transition segments.

3. EyePoint, Inc. (NASDAQ:EYPT)

Upside Potential as of July 2, 2026: 153.93%

Andreas Argyrides, an analyst at Chardan, significantly lifted the price target on EyePoint, Inc. (NASDAQ:EYPT) to $65 from $29 on July 1. Calling the company “a de-risked, single-asset, catalyst-rich story,” the firm maintained a Buy rating on the shares following a transfer of coverage.

The firm expects readouts from Phase 3 studies of DURAVYU in wet AMD, scheduled for August and October 2026, to be the key catalysts. The two biggest retinal markets, wet AMD and DME, are anticipated to achieve $13 billion in U.S. sales next year, the firm said.

In one year, EyePoint, Inc. (NASDAQ:EYPT) has returned twice as much as the market, with nearly 25% outperformance. Overall, the company has a Buy rating from all twelve analysts covering the stock. With an upside potential of 153.93% based on the one-year median price target of $35.50, EYPT is among the best get rich quick stocks to buy right now.

EyePoint, Inc. (NASDAQ:EYPT) is a Massachusetts-based company specializing in therapeutics for people living with serious retinal diseases. The company’s pipeline is built on its proprietary bioerodible Durasert E technology.

2. Neumora Therapeutics, Inc. (NASDAQ:NMRA)

Upside Potential as of July 2, 2026: 199.40%

On June 18, Mizuho lowered the price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to $4, down from $6. This came after the company’s negative Phase 3 KOASTAL-2 and -3 study outcomes. The firm has now removed navacaprant for depression from its financial model.

While highlighting the company’s pipeline, Mizuho reiterated an Outperform rating on Neumora Therapeutics, Inc. (NASDAQ:NMRA). Although still in early stages, the pipeline is “highly intriguing,” the analyst said. The company is developing NMRA-511, which is currently in Phase 1b clinical trials for Alzheimer’s disease agitation, as well as NMRA-861 and NMRA-898.

The firm’s model incorporates contributions from the clinical-stage assets. With that said, Mizuho anticipates critical updates for each program in the latter half of this year. The Street projects an upside potential of 199.40% for Neumora Therapeutics, Inc. (NASDAQ:NMRA), making it one of the best get rich quick stocks to buy right now.

The company also saw price cuts from two other firms. On June 16, Needham trimmed the price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to $5 from $8 and reaffirmed a Buy rating. On the same day, H.C. Wainwright also reduced the price target on the company from $18 to $7. The firm maintained a Buy rating.

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is a Massachusetts-based clinical-stage biopharmaceutical company that develops therapeutic solutions for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases.

1. Omeros Corporation (NASDAQ:OMER)

Upside Potential as of July 2, 2026: 374.14%

On June 26, Brandon Folkes from H.C. Wainwright trimmed the price target on Omeros Corporation (NASDAQ:OMER) to $33 from $40 and reaffirmed a Buy rating. This price revision follows a “disappointing” negative CHMP opinion for Yartemlea. While the news is likely to weigh on the stock in the near term, the analyst believes it isn’t entirely “thesis-breaking.”

Folkes views the U.S. Yartemlea launch as a key value driver for Omeros Corporation (NASDAQ:OMER). The price cut is based on the firm’s removal of the EU opportunity from its model and the higher R&D spending guidance.

What’s truly impressive is the company’s one-year return. Omeros Corporation (NASDAQ:OMER) delivered a solid return of 200.32% in contrast to the S&P 500’s return of 20.17%. While the company’s year-to-date performance is negative, its upside potential is approximately 374%. With that, OMER is among the best get rich quick stocks to buy right now.

Omeros Corporation (NASDAQ:OMER), incorporated in 1994, is a Washington-based clinical-stage biopharmaceutical company specializing in small-molecule and protein therapeutics.

Disclosure: None. Follow Insider Monkey on Google News.